New Two-Pronged attack on cancer enters human testing
Disease control
Recruiting now
This early-stage study is testing a new drug called OTP-01 in adults with advanced solid tumors that have progressed after standard treatments. The main goals are to find the safest and most effective dose, understand how the body processes the drug, and see if it can shrink tumo…
Phase: PHASE1, PHASE2 • Sponsor: Ottimo Pharma Limited • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC